ITI is a California-based company formed in February 1994 to design, manufacture and market premium quality magnetic resonance imaging (MRI) medical devices and instruments. These products are for use in existing MR irnagers, as well as for emerging applications in reaI-tirne MRI-guided surgery and interventional radiology. Such application require products that are MR biocompatible and in many cases MR visible. In an era of managed health care, purchasing decisions by hospitals, medical centers and insurers emphasize cost-effectiveness. Since minimally invasive therapy reduces surgical costs, shortens hospital stay and post-operative rehabilitation, this segment of the health care industry is expected to grow rapidly. Many experts believe that high-speed MRI-guided therapy offers the best opportunity to maximize the benefits of minimally invasive procedures because MIH enables the clearest differentiation of normal from abnormal tissues. Manufacturers of conventional imagers, including General Electric, Siemens, and Philips, have aleady made substantial investments aid produced prototype high-speed MRI.imagers to permit continuous real-time visualization of tissues during surgical and endovascular procedures. According to forecasts published by the National Electrical Manufacturers Association (1993) and the Medical and Healthcare Marketplace Guide (1992), the average world~wide growth rate of MN installations is expected to be about 7% annually for the next three years, increasing 12-15% annually thereafter as developing countries buy increasing numbers of MM units. The same forecasters project 17,000- 20,000 MRI irnagers world-wide by the year 2000, with a throughput of 2,300-6,000 patients per machine per year, at an.average examination cost.of $560-780-per-patient.